Compositions and methods for treating cystic fibrosis

Details for Australian Patent Application No. 2008316663 (hide)

Owner Revalesio Corporation

Inventors Watson, Richard L.; Wood, Anthony B.; Archambeau, Gregory J.

Agent Davies Collison Cave

Pub. Number AU-A-2008316663

PCT Pub. Number WO2009/055671

Priority PCT/ US2007/082581 25.10.07 US; 60/982,720 25.10.07 US; PCT/ US2007/082578 25.10.07 US; 61/048,332 28.04.08 US; PCT/ US2007/082580 25.10.07 US; 60/982,719 25.10.07 US; 61/048,347 28.04.08 US; 61/048,404 28.04.08 US; 61/048,340 28.04.08 US

Filing date 24 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/055671 Priority application(s): WO2009/055671

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316667-Methods of identifying histone deacetylase inhibitors useful for neurological disorders

2008316662-Non-pneumatic tire